Robert H Hyland, DPhil
Gilead Sciences
3
0
3
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Ming-Lung Yu, MD, PhD
Kaohsiung Medical University
Shared therapeutic areas:
Mostafa Gabr, MD
Cairo University
Shared therapeutic areas:
Wahid Doss, MD
Cairo University
Shared therapeutic areas:
Mohamed A Afify, MD
Cairo University
Shared therapeutic areas:
Gamal Sheha, MD
Cairo University
Shared therapeutic areas:
Noaman Al-Garem, MD
Cairo University
Shared therapeutic areas:
Pei-Jer Chen, MD, PhD
National Taiwan University Hospital
Shared therapeutic areas:
Kazuoki Kondo, M.D.
Tanabe Pharma Corporation
Shared therapeutic areas:
Shih-Jer Hsu, MD
National Taiwan University Hospital, Yun-Lin Branch
Shared therapeutic areas:
Gamal Esmat, MD
Cairo University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection
Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin in Cirrhotic Subjects With Chronic Genotype 1 HCV Infection
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders
All 3 trials loaded